MedTrace Logo

MLC901 in Moderate Traumatic Brain Injury

NCT04766281 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-06-13

No results posted yet for this study

Summary

This study wants to evaluate whether MLC901 will help improve the condition of adult patients with moderate traumatic brain injury.

Conditions

  • Moderate Traumatic Brain Injury

Interventions

DIETARY_SUPPLEMENT

MLC901

This consists of extracts from 9 herbal components in a dark blue/light blue capsule

GENETIC

Placebo

This consists of a dark brown powder in size 0 dark blue/light blue vegetable capsule

Sponsors & Collaborators

  • University of the Philippines

    lead OTHER

Principal Investigators

  • Annabell E Chua, MD · University of the Philippines Manila - Philippine General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2024-05-30
Completion
2024-07-31

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766281 on ClinicalTrials.gov